Skip to main content

Published locations for Heart failure hospitalization risk lower with SGLT2 inhibitors than GLP-1 RAs

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Heart failure hospitalization risk lower with SGLT2 inhibitors than GLP-1 RAs

User login

  • Reset your password
  • /content/heart-failure-hospitalization-risk-lower-sglt2-inhibitors-glp-1-ras
  • /internalmedicinenews/article/246716/diabetes/heart-failure-hospitalization-risk-lower-sglt2
  • /hospitalist/article/246716/diabetes/heart-failure-hospitalization-risk-lower-sglt2-inhibitors-glp-1
  • /clinicalendocrinologynews/article/246716/diabetes/heart-failure-hospitalization-risk-lower-sglt2
  • /cardiology/article/246716/diabetes/heart-failure-hospitalization-risk-lower-sglt2-inhibitors-glp-1
  • /endocrinology/article/246716/diabetes/heart-failure-hospitalization-risk-lower-sglt2-inhibitors-glp
  • /internalmedicine/article/246716/diabetes/heart-failure-hospitalization-risk-lower-sglt2-inhibitors
  • /type-2-diabetes-icymi/article/246716/diabetes/heart-failure-hospitalization-risk-lower-sglt2